Trial intelligence / Profile preview

PDRN in lumbar spinal stenosis

NCT04401735Phase 4Unknown

Sponsor
Seoul National University Hospital
Start
Nov 2019
Primary completion
May 2020
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of polideoxirybonucleotide in lumbar spinal stenosis (LSS), sponsored by Seoul National University Hospital. Status: unknown.

02

Drugs

polideoxirybonucleotide
03

Conditions

lumbar spinal stenosis (LSS)

Beyond the preview

Go deeper on NCT04401735.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04401735.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call